Paper24700706
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
Morice MC and 14 others. Circulation, 2014. Cited by 397 papers, by iCite.
Cite this record
ConductScience Library. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Papers, record 24700706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24700706
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
- PubMed
- Publication types
- Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Bypass | Major topic |
| Coronary Artery Disease | Major topic |
| Drug-Eluting Stents | Major topic |
| Paclitaxel | Major topic |
| Percutaneous Coronary Intervention | Major topic |
| Adult | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Incidence | |
| Male | |
| Risk Factors | |
| Treatment Outcome | |
| Tubulin Modulators |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00114972 | SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT03417050 | Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival | Background | ClinicalTrials.gov | |
| NCT05258318 | Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24755917 | Coronary artery disease: Similar 5-year outcomes with CABG surgery or PCI for left main disease. | https://conductscience.org/library/papers/24755917 |
Source PubMed
Cited by158
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 397 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42501240 | Impact of stent size selection during a single stenting with kissing balloon inflation for left main bifurcation lesions. | Cardiovasc Interv Ther | 2026 | https://conductscience.org/library/papers/42501240 | PubMed |
| 42438235 | Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 2. | Korean Circ J | 2026 | https://conductscience.org/library/papers/42438235 | PubMed |
| 42368217 | Protected percutaneous coronary intervention of complex distal left main disease with Impella CP™ support. | Eur Heart J Suppl | 2026 | https://conductscience.org/library/papers/42368217 | PubMed |
| 42239549 | Middle East Bifurcation Club Consensus Document on Percutaneous Revascularization of Bifurcation Lesions in Association with the National Heart Center - Saudi Health Council. | Saudi Med J | 2026 | https://conductscience.org/library/papers/42239549 | PubMed |
| 41714707 | Invasive and medical management approaches to non-acute myocardial ischaemic syndromes. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/41714707 | PubMed |
| 41548856 | Avenues for optimization of cardiac therapeutics by minimally invasive delivery. | Acta Biomater | 2026 | https://conductscience.org/library/papers/41548856 | PubMed |
| 41449451 | Total coronary revascularization with anterior thoracotomy: it's not just about sternotomy. | J Cardiothorac Surg | 2025 | https://conductscience.org/library/papers/41449451 | PubMed |
| 41294178 | Guideline for Chronic Coronary Syndrome - 2025. | Arq Bras Cardiol | 2025 | https://conductscience.org/library/papers/41294178 | PubMed |
| 41184891 | Recent insights into the pathophysiology and implications for surgery in atherosclerosis. | J Cardiothorac Surg | 2025 | https://conductscience.org/library/papers/41184891 | PubMed |
| 41114310 | Clinical outcomes of double kissing crush or double kissing culotte technique in left main bifurcation lesions: the MAIN-ROUTE registry. | Postepy Kardiol Interwencyjnej | 2025 | https://conductscience.org/library/papers/41114310 | PubMed |
| 40924282 | Outcomes after percutaneous coronary intervention or coronary artery bypass grafting in patient with left main coronary artery disease: the TOkai LEft main RevAscularizatioN sTrategy (TOLERANT) study. | Cardiovasc Interv Ther | 2026 | https://conductscience.org/library/papers/40924282 | PubMed |
| 40794424 | The role of microparticles in oxidative stress and inflammation in patients with vascular intimal hyperplasia. | J Int Med Res | 2025 | https://conductscience.org/library/papers/40794424 | PubMed |
| 40710433 | Long-Term Outcome of Unprotected Left Main Percutaneous Coronary Interventions-An 8-Year Single-Tertiary-Care-Center Experience. | J Pers Med | 2025 | https://conductscience.org/library/papers/40710433 | PubMed |
| 40476636 | Stenting strategy and imaging use in left main percutaneous coronary intervention: insights from a 15-year registry. | Future Cardiol | 2025 | https://conductscience.org/library/papers/40476636 | PubMed |
| 40422950 | Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry. | J Cardiovasc Dev Dis | 2025 | https://conductscience.org/library/papers/40422950 | PubMed |
| 40004691 | The European Society of Cardiology 2024 Guidelines on Chronic Coronary Syndromes: A Critical Appraisal. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004691 | PubMed |
| 39860334 | Complex Left Main Trifurcation: A Case Study of Successful Treatment. | J Clin Med | 2025 | https://conductscience.org/library/papers/39860334 | PubMed |
| 39493943 | Left Main Percutaneous Coronary Revascularization. | US Cardiol | 2023 | https://conductscience.org/library/papers/39493943 | PubMed |
| 39431313 | Prognostic value of pan immune-inflammation value in patients undergoing unprotected left main coronary artery stenting. | Biomark Med | 2024 | https://conductscience.org/library/papers/39431313 | PubMed |
| 39077332 | Left Main Coronary Artery Disease: A Contemporary Review of Diagnosis and Management. | Rev Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39077332 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24700706
GET https://conductscience.org/api/papers/v1/24700706/cited_by?page=2